In 2020, a large‐scale genomic study that integrated global matchmaking for rare‐disease cases reported on the discovery of autosomal dominant heterozygous variants in IMPDH2, encoded by IMPDH2, in patients with dystonia.20 This evidence concerns the gene IMPDH2 and Dystonia.